“The First Data on International Multicenter Clinical Study RheoSTAT-CP0691 on the Efficacy and Safety of Rheosorbilact® Infusion in Therapy of Purulent Peritonitis”. Perioperaciina Medicina, vol. 5, no. 1, May 2022, pp. 34-46, https://doi.org/10.31636/prmd.v5i1.5.